gabexate and 3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one

gabexate has been researched along with 3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Imanishi, N; Komuro, Y; Morooka, S	1

Other Studies

1 other study(ies) available for gabexate and 3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one

Article	Year
Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC). Lipids, 1991, Volume: 26, Issue:12 Topics: Administration, Oral; Animals; Disseminated Intravascular Coagulation; Endotoxins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Infusions, Intravenous; Injections, Intraperitoneal; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Count; Prothrombin Time; Rats; Thiazoles; Thiazolidines	1991

Article

Year

Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).

Lipids, 1991, Volume: 26, Issue:12

Topics: Administration, Oral; Animals; Disseminated Intravascular Coagulation; Endotoxins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Infusions, Intravenous; Injections, Intraperitoneal; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Count; Prothrombin Time; Rats; Thiazoles; Thiazolidines

1991